Zydus Cadila gets tentative nod from USFDA to market cancer drug

Zydus Cadila gets tentative nod from USFDA to market cancer drug The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Ibrutinib tablets, in the strengths of 140 mg, 280 mg, 420 mg and 560 mg, Zydus Cadila said in a statement. https://ift.tt/eA8V8J